- Bioidentical hormone pellets are implanted and cannot be removed once placed, which makes dose errors last months rather than days.
- Creams and injections adjust quickly, which makes them easier to titrate against a lab panel every 90 days.
- Every form should be guided by labs rather than symptoms alone, which is the entire argument for a Biomarker Audit cadence.
- The $299 monthly fee covers the clinician across any of these delivery forms and never changes with the dose.
Among hormone patients, the debate over bioidentical hormone pellets vs creams vs injections is a big one. Some patients arrive convinced pellets are the premium option. Others arrive after a bad pellet experience and want their old cream back. The honest answer depends on what you want from your dosing and how closely you want it tied to your labs.
We start from one principle. A delivery form is only as good as the monitoring behind it. A pellet that is never checked against a panel is a guess with a long half-life.
What bioidentical actually means
Bioidentical hormones have the same molecular structure as the hormones your own body makes. Estradiol, progesterone and testosterone can all be prescribed this way. The term says nothing about the delivery form, which is where the pellet, cream and injection conversation actually lives.
Compounded bioidentical hormone therapy, including BIEST, is offered inside our membership where clinically appropriate. What distinguishes good hormone care from a peptide menu is not the delivery form. It is whether a lab panel sits underneath every dose decision.
How the three forms differ
| Feature | Pellets | Creams | Injections |
|---|---|---|---|
| Dosing interval | Every 3 to 6 months | Daily | Weekly to twice weekly |
| Ability to adjust | None once implanted | High, change tomorrow | High, change next dose |
| Peak and trough pattern | Smooth but fixed | Moderate fluctuation | Visible peaks and troughs |
| Fit with quarterly labs | Harder, since the dose cannot respond between insertions | Natural fit for quarterly audits | Natural fit for quarterly audits |
| Reversibility | Surgical removal if needed | Stop applying | Skip the next dose |
The pellet problem, stated plainly
A pellet delivers a fixed dose for months. If the dose turns out to be too high for you, the only fix is removal, which is a procedure. If it is too low, you wait for it to run down. This is why we treat pellets as a consideration only after a stable, lab-confirmed dose has been established, rather than as a starting point.
Patients often arrive wanting pellets for convenience. We understand that. Convenience is a real good. What we ask you to weigh is convenience against the ability to respond to a lab result, which is what keeps hormone therapy safe over years rather than months.
Creams and injections and when they fit
Creams and injections adjust within days. They pair naturally with a quarterly Biomarker Audit, where the dose follows the panel rather than the calendar. For most patients starting hormone optimization, this is the form we begin with. It gives us room to find the lowest effective dose before locking anything in.
Injections offer the most predictable absorption for testosterone in men and are our usual starting form there. Creams suit patients who prefer not to inject and whose levels respond well on them. Neither is superior in the abstract. Both are superior to an unmonitored pellet.
The monitoring standard
Whatever the form, the standard is the same. A full hormone and thyroid panel at intake, then again every 90 days. Estradiol, progesterone, testosterone, SHBG, TSH and free T4, read together rather than one line at a time.
This is where the pellet conversation gets concrete. If you choose pellets, the monitoring still matters, but the dose cannot respond to what the labs find. If you choose a cream or injection, the panel directly shapes the next prescription. We think that responsiveness is the safer default for most patients.
Why the flat fee matters here
Hormone care is a years-long relationship, not a one-time decision. A model that charges by visit makes monitoring expensive and expensive monitoring gets skipped. Our $299 monthly fee covers the clinician and the quarterly Biomarker Audit indefinitely. There is no per-visit charge to make you think twice about asking a question and there is no dose-based pricing to make escalation attractive to anyone.
The medicine, including bioidentical hormones, is billed separately by the pharmacy at pharmacy cost. Zero markup. Those are the two charges and they stay separate.
Who we built this protocol for
The patients who thrive in this model tend to arrive after a bad experience elsewhere. Maybe a pellet was placed on the basis of symptoms alone. Maybe a cream dose was set by a questionnaire rather than a panel. Maybe nobody has drawn a single lab in two years of hormone therapy.
If any of that sounds familiar, you are not asking for a different delivery form. You are asking for a clinician who treats the panel as the source of truth and adjusts accordingly. That is the care our physicians deliver and it is why our patients stay with us.
Frequently asked questions
Are bioidentical hormones safer than synthetic ones?
Bioidentical hormones match the molecular structure of endogenous hormones. Whether they are safer depends on the clinical context, the dose and the monitoring. They are not automatically safer. They are an option our clinicians consider when the evidence and the panel support them.
Can pellets be removed once implanted?
Yes, but removal is a minor procedure rather than simply skipping a dose. This is why we prefer forms that adjust within days until a dose has been confirmed stable across audits.
How long until hormone levels stabilize on a cream or injection?
Most patients reach a workable steady state within weeks and the first quarterly audit is where we confirm it against the full panel and adjust from there.
Do you require labs before starting hormone therapy?
Always. A full hormone and thyroid panel at intake is the foundation of every protocol we write. Dosing without a baseline panel is guessing and guessing with hormones has a long shadow.
Is BIEST the same as regular bioidentical estrogen?
BIEST combines estriol and estradiol in a fixed ratio. It is one option among several and the choice between it and estradiol alone is a clinical decision our physicians make against the panel and the symptom picture.
Can I switch from pellets to a cream?
Yes. Patients do this often, usually after a pellet dose ran too high or too low. The transition is planned around the pellet taper so levels move predictably rather than abruptly.
Does testosterone therapy apply to women in your protocols?
Yes, at much lower doses than men and only when the panel and symptoms support it. Low testosterone in women is real and is one of the treatable findings our hormone panel catches.
What does this cost with the membership?
The $299 monthly fee covers the clinician and the quarterly Biomarker Audit. The hormone prescription is billed separately by the pharmacy at pharmacy cost with zero markup. Those two charges stay separate and neither changes with the dose.
Related guides
- Bioidentical vs synthetic hormones: what patients should know
- Hormone optimization for women in perimenopause
- Low testosterone symptoms in men: what labs actually show
- Hormone optimization
Sources
- The Endocrine Society, bioidentical hormone therapy position resources
- FDA, concerns with unapproved GLP-1 drugs used for weight loss
References
- Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. 2015. doi.org/10.1210/jc.2015-2236
- Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018. doi.org/10.1210/jc.2018-00229